Prostate Cancer - Results from #22080

Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: The ZABTON-PC (Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer) study - Abstract October 11, 2013

Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapy - Abstract October 11, 2013

Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer - Abstract October 11, 2013

Pelvic floor musculature and bladder neck changes before and after continence recovery after radical prostatectomy in pelvic MRI - Abstract October 11, 2013

Image-guided radiotherapy with implanted markers and kilovoltage imaging and 6-dimensional position corrections for intrafractional motion of the prostate - Abstract October 11, 2013

Intrusive thoughts and quality of life among men with prostate cancer before and three months after surgery - Abstract October 11, 2013

The validity of the distress thermometer in prostate cancer populations - Abstract October 11, 2013

Efficacy of estramustine phosphate sodium hydrate (EMP) monotherapy in castration-resistant prostate cancer patients: Report of 102 cases and review of literature - Abstract October 10, 2013

Multidetector CT imaging of post-robot-assisted laparoscopic radical prostatectomy complications - Abstract October 10, 2013

Evolution of advanced technologies in prostate cancer radiotherapy - Abstract October 10, 2013

High level of dioxin-TEQ in tissue is associated with Agent Orange exposure but not with biochemical recurrence after radical prostatectomy - Abstract October 10, 2013

Intraductal carcinoma of the prostate: The whole story - Abstract October 10, 2013

Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience - Abstract October 10, 2013

Reduction in radiation-induced lymphocytopenia by famotidine in patients undergoing radiotherapy for prostate cancer - Abstract October 10, 2013

Accurate IMRT fluence verification for prostate cancer patients using 'in-vivo' measured EPID images and in-room acquired kilovoltage cone-beam CT scans - Abstract October 10, 2013

Educational benefits of Internet and computer-based programmes for prostate cancer patients: A systematic review - Abstract October 10, 2013

Clinical comparison between a currently available single-loop and an investigational dual-channel endorectal receive coil for prostate magnetic resonance imaging: A feasibility study at 1.5 and 3 T - Abstract October 10, 2013

Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer - Abstract October 9, 2013

Robot-assisted radical prostatectomy for the treatment of radiation-resistant prostate cancer: Surgical, oncological and short-term functional outcomes - Abstract October 9, 2013

Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer - Abstract October 9, 2013

Page 1105 of 1436